Breaking News
Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data

Last week's biggest management and board changes: Kohl's, Biogen, adidas

Stock Markets Nov 13, 2022 16:24
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters
 
NOVN
-0.47%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ADSGN
-0.91%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BBBY
+12.55%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BIIB
-1.43%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KSS
-0.22%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
KDP
+0.06%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Sarina Isaacs and Senad Karaahmetovic

Investing.com - Here are the biggest management and board changes from the past week, as first reported on InvestingPro+.

Keurig Dr Pepper (NASDAQ:KDP) announced the resignation of Ozan Dokmecioglu as Chief Executive Officer and a member of the KDP Board of Directors. Bob Gamgort, the Company's current Executive Chairman and former CEO, was reappointed by the Board to the role of CEO, in addition to continuing as Chairman.

Bed Bath & Beyond Inc (NASDAQ:BBBY) announced the appointment of Bart Sichel as EVP, Chief Marketing & Customer Officer. Mr. Sichel will oversee fully integrated marketing and customer strategies for Bed Bath & Beyond, buybuy BABY and Harmon, reporting directly to Bed Bath & Beyond Inc. President and CEO, Sue Gove. "Bart has an excellent track record when it comes to building brands, driving brand loyalty, marketing strategy, advertising, and customer insights and analytics," said Gove.

Biogen Inc (NASDAQ:BIIB) announced that its Board of Directors has appointed Christopher A. Viehbacher as President and Chief Executive Officer and a member of the Board of Directors, effective November 14. Viehbacher succeeds Michel Vounatsos, who has led the company since 2017. According to the company, Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies.

Kohl's Corp (NYSE:KSS) announced that its CEO Michelle Gass plans to step down as CEO and member of the Kohl’s Board of Directors starting from December 2, 2022. Tom Kingsbury will serve as interim CEO until a permanent successor is named. Kingsbury stated, “I’m proud and humbled to take the Interim CEO role during such an important time for the Company." Kohl's shares were down about 37% year-to-end based on Friday's close.

The Supervisory Board of Adidas AG (ETR:ADSGN) (OTC:ADDYY) named Bjørn Gulden to be CEO and member of the Executive Board and CEO, effective January 1, 2023. He succeeds Kasper Rorsted, who agreed with the Supervisory Board that he will step down as CEO and leave the company upon expiry of November 11, 2022. Harm Ohlmeyer, Chief Financial Officer of adidas AG, will lead the company in the interim until December 31, 2022.

Manulife Financial Corp (NYSE:MFC) announced the appointment of Don Lindsay as Vice Chair of the Board of Directors of Manulife Financial Corporation and The Manufacturers Life Insurance Company. "John Cassaday will retire on February 15, 2023 after thirty years of distinguished service as a member of the Board, and as Chairman for the past five years, at which time Don will become Chair of the Board," said the company.

Seagen Inc (NASDAQ:SGEN) announced that its Board of Directors has appointed David R. Epstein as CEO and a member of the Board of Directors. "Mr. Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world and then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG," said the company.

Last week's biggest management and board changes: Kohl's, Biogen, adidas
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email